Live from the NIH registry
Studies recruiting near Murfreesboro right now
Top 25 of 83 recruiting studies, sorted by proximity — each links to its official registry page
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Vanderbilt-Ingram Cancer Center at Franklin — Franklin, Tennessee (26.1 mi)
· Sponsor: NRG Oncology
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
B-cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 164 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Hermitage, Tennessee (26.7 mi)
· Sponsor: Hoffmann-La Roche
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Psychiatric Consultants, Pc — Franklin, Tennessee (26.1 mi)
· Sponsor: Bristol-Myers Squibb
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Delricht Research - Smyrna — Smyrna, Tennessee (11.0 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
Clinical Trials Center of Middle Tennessee, LLC — Franklin, Tennessee (26.1 mi)
· Sponsor: United Therapeutics
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Mount Juliet, Tennessee (25.0 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Tennessee Oncology, PLLC - Murfreesboro — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Pfizer
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 200 participants sought
Oruka Therapeutics Investigative Site — Smyrna, Tennessee (11.0 mi)
· Sponsor: Oruka Therapeutics, Inc.
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
N/A
Interventional 6,800 participants sought
Neuroscience and TMS Treatment Center — Brentwood, Tennessee (24.3 mi)
· Sponsor: LivaNova
The Fourth Left Atrial Appendage Occlusion Study
Atrial Fibrillation, Stroke, Ischemic
N/A
Interventional 4,000 participants sought
Glanecare, Inc. d/b/a HCA Florida Brandon Hospital — Brentwood, Tennessee (24.3 mi)
· Sponsor: Hamilton Health Sciences Corporation
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Mount Juliet, Tennessee (25.0 mi)
· Sponsor: TG Therapeutics, Inc.
Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults
Ocular Hyperemia
Phase 3
Interventional 230 participants sought
Advancing Vision Research, LLC — Smyrna, Tennessee (11.0 mi)
· Sponsor: Alcon Research
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1, Phase 2
Interventional 83 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Abnormal Uterine Bleeding (AUB), Endometrial Cancer
N/A
Observational 4,200 participants sought
Murfreesboro Medical Clinic — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Exact Sciences Corporation
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,500 participants sought
International Clinical Research - Tennessee LLC /ID# 259552 — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: AbbVie
Study of EVO756 in Adults With Migraine
Migraine
Phase 2
Interventional 330 participants sought
Campbell Clinical Research — Franklin, Tennessee (26.1 mi)
· Sponsor: Evommune, Inc.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - 007-928-F — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 675 participants sought
International Clinical Research - Tennessee /ID# 268548 — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: AbbVie
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Interventional 987 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Lichen Planopilaris
Phase 2, Phase 3
Interventional 342 participants sought
Clinical Trial Site — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Priovant Therapeutics, Inc.
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
DelRicht Research - Thompson's Station- Site Number : 8400041 — Smyrna, Tennessee (11.0 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Obesity and Overweight
Phase 3
Interventional 3,501 participants sought
Civia Health Nashville — La Vergne, Tennessee (14.9 mi)
· Sponsor: Pfizer
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 150 participants sought
Site 118 — Smyrna, Tennessee (11.0 mi)
· Sponsor: Spyre Therapeutics, Inc.
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Obesity or Overweight, Diabetes Mellitus, Type 2
Phase 3
Interventional 1,500 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca